Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

[Erythropoietic protoporphyria].

G Goerz

    Fortschritte Der Medizin
    |October 4, 1979
    PubMed
    Summary
    This summary is machine-generated.

    Erythropoietic protoporphyria (EEP) is an inherited metabolic disorder causing sun sensitivity due to increased protoporphyrins. Effective treatment with carotenoids offers a good prognosis for most patients.

    Related Concept Videos

    You might also read

    Related Articles

    Articles linked to this work by shared authors, journal, and citation graph.

    Sort by
    Same author

    Identification of mutations in the uroporphyrinogen III cosynthase gene in German patients with congenital erythropoietic porphyria.

    Physiological research·2007
    Same author

    A spectrum of novel mutations in the protoporphyrinogen oxidase gene in 13 families with variegate porphyria.

    The Journal of investigative dermatology·2001
    Same author

    [Acral necroses after therapy with quinine sulfate for calf cramps].

    Der Hautarzt; Zeitschrift fur Dermatologie, Venerologie, und verwandte Gebiete·2000
    Same author

    Treatment of porphyria cutanea tarda with oral thalidomide.

    Skin pharmacology and applied skin physiology·1999
    Same author

    Alterations of rat liver phospholipid composition induced by oral thalidomide.

    Skin pharmacology and applied skin physiology·1999
    Same author

    Erythropoietic protoporphyria: identification of novel mutations in the ferrochelatase gene and comparison of biochemical markers versus molecular analysis as diagnostic strategies.

    Journal of investigative medicine : the official publication of the American Federation for Clinical Research·1999
    Same journal

    [More information--less pain. Procedure in pain following amputation of limbs. Brachial plexus injury and nerve root avulsion. Interview by Susanne Kammerer].

    Fortschritte der Medizin·1999
    Same journal

    [Galenic alternatives to unstable tocopherol acetate. "Smeared" or cheated?--Vitamin E in facial ointments].

    Fortschritte der Medizin·1999
    Same journal

    [Gene diagnosis in the hand of the physician].

    Fortschritte der Medizin·1999
    Same journal

    [Is non-toxic cancer therapy through biotechnology a possibility?].

    Fortschritte der Medizin·1999
    Same journal

    [Smoking withdrawal in practice and clinic].

    Fortschritte der Medizin·1999
    Same journal

    [The future of pancreas diagnosis. An exclusive training service of the Gastro-Ligue for dermatologists].

    Fortschritte der Medizin·1999
    See all related articles

    Area of Science:

    • Biochemistry
    • Genetics
    • Dermatology

    Context:

    • Erythropoietic protoporphyria (EEP) is the most common erythropoietic porphyria.
    • It is an inherited metabolic disorder of heme synthesis with autosomal dominant inheritance.

    Purpose:

    • To describe the pathophysiology, clinical manifestations, and treatment of Erythropoietic protoporphyria.
    • To highlight the effectiveness of symptomatic treatment and the overall prognosis.

    Summary:

    • EEP results from ferrochelatase deficiency, leading to elevated protoporphyrins in red blood cells.
    • Sunlight exposure, particularly UV-A, triggers photohemolysis and skin lesions, ranging from acute sunburn-like reactions to persistent infiltrations.
    • Associated complications include gallstones and, rarely, liver cirrhosis.

    Related Experiment Videos

    Impact:

    • Understanding EEP aids in early diagnosis and management.
    • Effective treatment strategies, including photoprotection and carotenoids, improve patient outcomes and quality of life.
    • This research underscores the importance of managing metabolic disorders to prevent severe complications like hepatic failure.